Diebold Nixdorf (DBD) Reports In-Line Q4 Revenue
Get Alerts DBD Hot Sheet
Price: $55.05 -6.92%
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q4 EPS of $3.02, may not compare to the analyst estimate of $1.34. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.03 billion.
Full-year 2024 Outlook
- RevenueLow single-digit growth
- Adjusted EBITDA 1$410M - $435M
=
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Capri Holdings Limited (CPRI) Tops Q2 EPS by 21c; offers guidance
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share